NEJM Interviews
NEJM Interviews
NEJM Group
NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.
12 minutes Posted Feb 8, 2023 at 3:01 pm.
-485.
0:00
12:14
Download MP3
Show notes
Dr. Ameet Sarpatwari is an assistant professor of medicine at Harvard Medical School and the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital and Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.S. Tu and A. Sarpatwari. A “Method of Use” to Prevent Generic and Biosimilar Market Entry. N Engl J Med 2023;